LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 259 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 3.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,507,000 | +2.8% | 11,108 | +108.0% | 0.59% | +56.3% |
| Q3 2018 | $1,466,000 | +208.0% | 5,341 | +85.0% | 0.38% | +514.8% |
| Q1 2018 | $476,000 | -52.9% | 2,887 | -60.9% | 0.06% | -54.5% |
| Q4 2017 | $1,011,000 | -28.5% | 7,387 | -28.9% | 0.13% | -28.0% |
| Q3 2017 | $1,413,000 | +97.9% | 10,385 | +76.5% | 0.19% | +104.4% |
| Q2 2017 | $714,000 | -64.3% | 5,883 | -68.8% | 0.09% | -64.3% |
| Q1 2017 | $1,998,000 | -65.6% | 18,886 | -67.0% | 0.26% | -50.7% |
| Q4 2016 | $5,807,000 | -17.1% | 57,158 | -16.8% | 0.52% | -5.7% |
| Q3 2016 | $7,009,000 | +31.3% | 68,677 | +53.4% | 0.55% | +38.0% |
| Q2 2016 | $5,338,000 | +11.2% | 44,756 | -0.2% | 0.40% | +16.1% |
| Q1 2016 | $4,801,000 | +105.3% | 44,838 | +107.9% | 0.34% | +111.1% |
| Q4 2015 | $2,338,000 | – | 21,567 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |